Filing Details
- Accession Number:
- 0001179110-20-010673
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-26 20:45:37
- Reporting Period:
- 2020-10-22
- Accepted Time:
- 2020-10-26 20:45:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1298819 | A Robert Sinnott | 3838 West Parkway Blvd Salt Lake City UT 84120 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-10-22 | 6,043 | $65.48 | 6,043 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-10-22 | 6,043 | $82.00 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-10-23 | 577 | $0.00 | 577 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-10-23 | 259 | $85.86 | 318 | No | 4 | F | Direct | |
Common Stock | Disposition | 2020-10-26 | 318 | $84.74 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock - Settles Stock Appreciation Right | Disposition | 2020-10-22 | 30,000 | $0.00 | 30,000 | $65.48 |
Common Stock | Restricted Stock Units | Disposition | 2020-10-23 | 577 | $0.00 | 577 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
30,000 | 2019-08-16 | 2022-03-16 | No | 4 | M | Direct |
8,033 | No | 4 | M | Direct |
Footnotes
- The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.
- Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
- On October 23rd, 2017, the reporting person was granted 2,309 restricted stock units, vesting at 25% on each 23rd of October thereafter.